CEUS联合常规超声诊断乳腺非肿块型疾病的研究

doi:10.7517/issn.1674-0475.210814

摘要/Abstract

摘要： 本文探讨超声造影（CEUS）联合常规超声在乳腺非肿块型疾病良恶性鉴别中的应用价值。回顾性分析68例乳腺非肿块型病变患者的影像资料，以病理结果为金标准，对比分析常规超声、CEUS及两者联合的诊断价值。68例乳腺非肿块型病变中良性28例，恶性40例；常规超声特征中，良恶性病灶在微钙化、病灶周围血流分布方面差异有统计学意义（P<0.05）；CEUS中良恶性病灶在增强强度、均匀度、显影时间及穿支血管方面差异均有统计学意义（P<0.05），TIC定量参数中，良恶性病灶在TTP、PI、AUC方面差异有统计学意义。常规超声联合CEUS诊断乳腺非肿块型疾病良恶性敏感度、特异度、准确度、阳性预测值及阴性预测值分别为：90.00%、96.43%、92.65%、97.30%、87.10%，高于单独使用常规超声或CEUS （P<0.05）。CEUS联合常规超声可显著提高乳腺非肿块型疾病良恶性的诊断效能，具有较好的临床应用价值。

关键词: 超声造影, 常规超声, 乳腺非肿块型疾病

Abstract: The value of contrast-enhanced ultrasoun (CEUS) combined with conventional ultrasound in the differentiation of benign and malignant non-mass breast diseases was discussed. The imaging data of 68 patients with breast non mass lesions were analyzed retrospectively. The pathological results were the gold standard. The diagnostic value of conventional ultrasound, CEUS and their combination were compared and analyzed. Among 68 cases of breast non mass lesions, 28 cases were benign and 40 cases were malignant. There were significant differences in microcalcification and blood flow distribution between benign and malignant lesions (P<0.05). There were significant differences in enhancement intensity, uniformity, development time and perforating vessels between benign and malignant lesions in CEUS (P<0.05). In the quantitative parameters of TIC, there were significant differences in TTP, PI and AUC between benign and malignant lesions. The sensitivity, specificity, accuracy, positive predictive value and negative predictive value of conventional ultrasound combined with CEUS in the diagnosis of benign and malignant breast non mass diseases were 90.00%, 96.43%, 92.65%, 97.30%, 87.10%, was higher than that of conventional ultrasound or CEUS alone (P<0.05). CEUS combined with conventional ultrasound can significantly improve the diagnostic efficiency of benign and malignant non-mass breast diseases, and has good clinical value.

Key words: contrast-enhanced ultrasound, conventional ultrasound, non-mass breast diseases

伏晶, 刘爱玲, 王吉科. CEUS联合常规超声诊断乳腺非肿块型疾病的研究[J]. 影像科学与光化学, 2022, 40(1): 73-77.

FU Jing, LIU Ailing, WANG Jike. Research of CEUS Combined with Conventional Ultrasound in the Diagnosis of Non-Mass Breast Diseases[J]. IMAGING SCIENCE AND PHOTOCHEMISTRY, 2022, 40(1): 73-77.

参考文献

[1] Tsang J Y S, Tse G M. Molecular classification of breast cancer[J]. Advances in Anatomic Pathology, 2019, 27(1):27-35.
[2] Jafari S H, Saadatpour Z, Salmaninejad A, et al. Breast cancer diagnosis:Imaging techniques and biochemical markers[J]. Journal of Cellular Physiology, 2018, 233(7):5200-5213.
[3] Guo R R, Lu G L, Qin B J, et al. Ultrasound imaging technologies for breast cancer detection and management:A review[J]. Ultrasound in Medicine & Biology, 2018, 44(1):37-70.
[4] Geisel J, Raghu M, Hooley R. The role of ultrasound in breast cancer screening:The case for and against ultrasound[J]. Seminars in Ultrasound, CT, and MR, 2018, 39(1):25-34.
[5] Kim Y, Kim S H, Song B J, et al. Early prediction of response to neoadjuvant chemotherapy using dynamic contrast-enhanced MRI and ultrasound in breast cancer[J]. Korean Journal of Radiology, 2018, 19(4):682-691.
[6] Wang M, Feng H L, Liu Y Q, et al. Angiogenesis research in mouse mammary cancer based on contrast-enhanced ultrasonography[J]. Academic Radiology, 2018, 25(7):889-897.
[7] 徐平,杨敏,刘勇,等. 超声造影定性及定量分析鉴别乳腺良恶性非肿块型病变[J]. 中国医学影像技术, 2020, 36(12):1825-1829.
[8] Kuhl C K, Lehman C, Bedrosian I. Imaging in locoregional management of breast cancer[J]. Journal of Clinical Oncology, 2020, 38(20):2351-2361.
[9] Marinovich M L, Hunter K E, MacAskill P, et al. Breast cancer screening using tomosynthesis or mammography:A meta-analysis of cancer detection and recall[J]. Journal of the National Cancer Institute, 2018, 110(9):942-949.
[10] Miller A B. The role of screening mammography in the era of modern breast cancer treatment[J]. Climacteric, 2018, 21(3):204-208.
[11] Mann R M, Cho N, Moy L. Breast MRI:State of the art[J]. Radiology, 2019, 292(3):520-536.
[12] 刘芳欣, 郑慧, 王洲. 声触诊弹性成像定量技术及超声造影在鉴别诊断乳腺非肿块型良恶性病变中的应用价值[J]. 安徽医科大学学报, 2019, 54(2):286-291.
[13] Tong W J, Zhang X L, Luo J, et al. Value of multimodality imaging in the diagnosis of breast lesions with calcification:a retrospective study[J]. Clinical Hemorheology and Microcirculation, 2020, 76(1):85-98.
[14] 韩龄锋. 多模态超声联合评分法对乳腺非肿块型病变的诊断价值[D]. 泸州:西南医科大学, 2018.
[15] Li M, Li Q, Yin Q, et al. Evaluation of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of breast cancer[J]. Clinical and Translational Oncology, 2020, 23(4):709-717.
[16] 朱庆莉, 姜玉新, 孙强,等. 乳腺癌彩色多普勒血流显像的多因素分析[J]. 中华超声影像学杂志, 2006, 15(2):109-112.
[17] Li X, Li Y, Zhu Y, et al. Association between enhancement patterns and parameters of contrast-enhanced ultrasound and microvessel distribution in breast cancer[J]. Oncology Letters, 2018, 15(4):5643-5649.
[18] Liu J, Gao Y H, Li D D, et al.Comparative study of contrast-enhanced ultrasound qualitative and quantitative analysis for identifying benign and malignant breast tumor lumps[J]. Asian Pacific Journal of Cancer Prevention,2014, 15(19):8149-8153.
[19] 王媚瑜, 张一峰, 陈捷, 等.超声造影定量分析技术在乳腺导管内病变良恶性鉴别中的应用价值[J]. 上海交通大学学报(医学版), 2020, 40(4):514-518.
[20] Lehotska V, Rauova K, Vanovcanova L. Pitfalls of contrast enhanced ultrasound (CEUS) in determination of breast tumor biological dignity[J]. Neoplasma, 2018, 65(1):124-131.